Did This Cryptococcosis Patient Have HIV Coinfection?
作者信息
Kobayashi Zen
机构信息
Department of Neurology, JA Toride Medical Center, Japan.
出版信息
Intern Med. 2019 Dec 15;58(24):3619. doi: 10.2169/internalmedicine.3292-19. Epub 2019 Aug 6.
Abstract
摘要
相似文献
1
Did This Cryptococcosis Patient Have HIV Coinfection?
Intern Med. 2019 Dec 15;58(24):3619. doi: 10.2169/internalmedicine.3292-19. Epub 2019 Aug 6.
2
The Author's Reply to "Did This Cryptococcosis Patient Have HIV Coinfection?".
Intern Med. 2019 Dec 15;58(24):3621. doi: 10.2169/internalmedicine.3421-19. Epub 2019 Aug 6.
3
Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone.
Intern Med. 2019 Mar 15;58(6):843-847. doi: 10.2169/internalmedicine.1726-18. Epub 2018 Nov 19.
4
Monoclonal Antibodies versus Histone Deacetylase Inhibitors in Combination with Bortezomib or Lenalidomide plus Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma: An Indirect-Comparison Meta-Analysis of Randomized Controlled Trials.
J Immunol Res. 2018 Jun 27;2018:7646913. doi: 10.1155/2018/7646913. eCollection 2018.
5
Daratumumab plus lenalidomide and dexamethasone lenalidomide and dexamethasone in relapsed or refractory multiple myeloma: updated analysis of POLLUX.
Haematologica. 2018 Dec;103(12):2088-2096. doi: 10.3324/haematol.2018.194282. Epub 2018 Sep 20.
6
Elotuzumab in combination with lenalidomide and dexamethasone in patients with relapsed multiple myeloma: final phase 2 results from the randomised, open-label, phase 1b-2 dose-escalation study.
Lancet Haematol. 2015 Dec;2(12):e516-27. doi: 10.1016/S2352-3026(15)00197-0. Epub 2015 Nov 16.
7
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial.
Lancet Haematol. 2019 Sep;6(9):e448-e458. doi: 10.1016/S2352-3026(19)30109-7. Epub 2019 Jul 18.
8
Initial Therapy in Older Patients with Multiple Myeloma.
N Engl J Med. 2019 May 30;380(22):2172-2173. doi: 10.1056/NEJMe1904372.
9
Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial.
Lancet Oncol. 2016 Nov;17(11):1569-1578. doi: 10.1016/S1470-2045(16)30375-8. Epub 2016 Sep 17.
10
Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.
Lancet Oncol. 2016 Aug;17(8):1127-1136. doi: 10.1016/S1470-2045(16)30124-3. Epub 2016 Jul 9.
本文引用的文献
1
Disseminated Cryptococcosis in a Patient with Multiple Myeloma Treated with Daratumumab, Lenalidomide, and Dexamethasone.
Intern Med. 2019 Mar 15;58(6):843-847. doi: 10.2169/internalmedicine.1726-18. Epub 2018 Nov 19.
2
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.
Clin Infect Dis. 2010 Feb 1;50(3):291-322. doi: 10.1086/649858.
Zotero 插件